Are the bleeding time and PFA‐100® useful in the initial screening of patients with mucocutaneous bleedings of hereditary nature?
Open Access
- 11 May 2004
- journal article
- editorial
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 2 (6) , 890-891
- https://doi.org/10.1111/j.1538-7836.2004.00780.x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Inherited platelet-based bleeding disordersJournal of Thrombosis and Haemostasis, 2003
- von Willebrand Disease in a Pediatric-based Population - Comparison of Type 1 Diagnostic Criteria and Use of the PFA-100® and a von Willebrand Factor/Collagen-binding AssayThrombosis and Haemostasis, 2000
- Evaluation of Platelet Function with the PFA-100 System in Patients with Congenital Defects of Platelet SecretionThrombosis Research, 1999
- Use of a novel platelet function analyzer (PFA‐100™) with high sensitivity to disturbances in von willebrand factor to screen for von willebrand's disease and other disordersAmerican Journal of Hematology, 1999
- Use of a novel platelet function analyzer (PFA-100?) with high sensitivity to disturbances in von willebrand factor to screen for von willebrand's disease and other disordersAmerican Journal of Hematology, 1999
- Evaluation of the PFA-100® System in the Diagnosis and Therapeutic Monitoring of Patients with von Willebrand DiseaseThrombosis and Haemostasis, 1999
- Screening for von Willebrand Disease With a New Analyzer Using High Shear Stress: A Study of 60 CasesBlood, 1998
- Characterization of an In Vitro Platelet Function Analyzer, PFA-100™Clinical and Applied Thrombosis/hemostasis, 1996